Lymphadenopathy

Lymphadenopathy Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Lymphadenopathy from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
CT scan
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Lymphadenopathy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Lymphadenopathy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Lymphadenopathy
CDC on Lymphadenopathy
Lymphadenopathy in the news
Blogs on Lymphadenopathy
Directions to Hospitals Treating Lymphadenopathy
Risk calculators and risk factors for Lymphadenopathy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Shyam Patel [2] Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [3] Raviteja Guddeti, M.B.B.S. [4]

Synonyms and keywords: Lymph nodes enlarged; Enlarged lymph nodes; Lymphadenitis; Swollen lymph nodes; Swollen/enlarged lymph nodes

Overview

Lymphadenopathy (also known as "enlarged lymph nodes") refers to lymph nodes which are abnormal in size, number or consistency. Common causes of lymphadenopathy are infection, autoimmune disease, or malignancy. Lymphadenopathy may be classified according to distribution into 2 groups: generalized lymphadenopathy and localized lymphadenopathy. The pathogenesis of lymphadenopathy is characterized by the inflammation of lymph nodes. This process is primarily due to an elevated rate of trafficking of lymphocytes into the node from the blood, exceeding the rate of outflow from the node. Lymph nodes may also be enlarged secondarily as a result of the activation and proliferation of antigen-specific T and B cells (clonal expansion). Lymphadenopathy is very common, the estimated incidence of lymphadenopathy among children in the United States ranges from 35%- 45%. Patients of all age groups may develop lymphadenopathy. Lymphadenopathy is more commonly observed among children. Common complications of lymphadenopathy, may include: abscess formation, superior vena cava syndrome, and intestinal obstruction. Diagnostic criteria for malignant lymphadenopathy, may include: node > 2 cm, node that is draining, hard, or fixed to underlying tissue, atypical location (e.g. supraclavicular node), associated risk factors (e.g. HIV or TB), fever and/or weight loss, and splenomegaly. On the other hand, diagnostic criteria for benign lymphadenopathy, may include: node < 1 cm, node that is mobile, soft-or tender, and is not fixed to underlying tissue, typical location (e.g. supraclavicular node), no associated risk factors, and palpable and painful enlargement. Laboratory findings consistent with the diagnosis of lymphadenopathy, may include: elevated lactate dehydrogenase (LDH), mild neutropenia, and leukocytosis. There is no treatment for lymphadenopathy; the mainstay of therapy is treating the underlying condition.

Classification

• Lymphadenopathy may be classified according to distribution into 2 groups:

• Generalized lymphadenopathy
• Localized lymphadenopathy

Pathophysiology

• The pathogenesis of lymphadenopathy is characterized by the inflammation of lymph nodes. This process is primarily due to an elevated rate of trafficking of lymphocytes into the node from the blood, exceeding the rate of outflow from the node.
• The inmune response between the antigen and lymphocyte that leads to cellular proliferation and enlargement of the lymph nodes.
• Lymph nodes may also be enlarged secondarily as a result of the activation and proliferation of antigen-specific T and B cells (clonal expansion).
• On gross pathology, characteristic findings of lymphadenopathy, include:

• Enlarged lymph node
• Soft greasy yellow areas within capsule

• On microscopic histopathological analysis, characteristic findings of lymphadenopathy will depend on the aetiology.
• Common findings, include:

Non-specific reactive follicular hyperplasia (NSRFH)

• Large spaced cortical follicles
• Tingible body macrophages, normal dark/light GC pattern

Lymph node metastasis

• Foreign cell population (usually in subcapsular sinuses)
• +/-nuclear atypia
• +/-malignant architecture

Toxoplasmosis

• Large follicles
• Epithelioid cells perifollicular & intrafollicular
• Reactive GCs
• Monocytoid cell clusters

Cat-scratch disease

• PMNs in necrotic area
• "Stellate" (or serpentine) shaped micro-abscesses
• Presence of granulomas

Dermatopathic lymphadenopathy

• Melanin-laden histiocytes
• Histiocytosis

Systemic lupus erythematosus lymphadenopathy

• Blue hematoxylin bodies
• Necrosis
• No PMNs

Differentiating Lymphadenopathy from other Diseases

• Lymphadenopathy must be differentiated from syphilis, which may present as fever, myalgias, weight loss, and lymph node enlargement.

Risk Factors

• The most common risk factors in the development of lymphadenopathy, include:

• Local soft-tissue infections
• Upper respiratory tract infection
• Foreign travel

Natural History, Complications and Prognosis

• Patients with lymphadenopathy may be symptomatic or asymptomatic, depending on the aetiology.
• Early clinical features include palpable tenderness, pain, and fever.

• Common complications of lymphadenopathy, include:

Mediastinal lymphadenopathy

• Superior vena cava syndrome
  • Tracheal and bronchial obstruction
  • Dysphagia
  • Hemoptysis
• Uric acid nephropathy
• Hyperkalemia
• Hypercalcemia
• Hypocalcemia
• Hyperphosphatemia
• Renal failure

Abdominal lymphadenopathy

• Intestinal obstruction

Superficial lymphadenopathy

• Abscess formation
• Cellulitis
• Fistulas (seen in lymphadenitis that is due to tuberculosis)
• Sepsis
• Prognosis will depend on the aetiology of the underlying disease.

Diagnosis

Diagnostic Criteria

Malignant Lymphadenopathy

• Node > 2 cm
• Node that is draining, hard, or fixed to underlying tissue
• Atypical location (e.g. supraclavicular node)
• Risk factors (e.g. HIV or TB)
• Fever and/or weight loss
• Splenomegaly

Benign Lymphadenopathy

• Node < 1 cm
• Node that is mobile, soft-or tender, and is not fixed to underlying tissue
• Common location (e.g. supraclavicular node)
• No associated risk factors
• Palpable and painful enlargement

Symptoms

• Symptoms of lymphadenopathy may include the following:

• Constitutional symptoms

• Fever
• Weight loss
• Fatigue
• Night sweats

• Malaise
• Nausea and vomiting
• Cachexia

• A directed history should be obtained to ascertain:

• Use of drugs causing lymphadenopathy
• Travel to endemic areas
• Occupational risk (e.g. Fishermen, slaughterhouse workers, hunters, trappers)
• High risk behavior or high risk sexual behaviors (e.g. I.V drug abuse, multiple partners)

Head

Palpating Anterior Cervical Lymph Nodes

Lymph nodes should be examined in the following order:

• Anterior Cervical
• Posterior Cervical
• Tonsillar
• Sub-Mandibular
• Sub-Mental
• Supra-clavicular

Characteristics to be noted while palpating lymph nodes:

• Size
• Pain/ tenderness

• Increased tenderness (e.g infected lymph nodes)

• Consistency
• Matting

Gallery

• 

  Cervical adenopathy: massive right side cervical adenopathy and facial asymmetry due to metastatic, intraoral squamous cell cancer. Images Courtesy of Charlie Goldberg, M.D., UCSD School of Medicine and VA Medical Center, San Diego, CA.

• 

  Cervical adenopathy: massive right side cervical adenopathy and facial asymmetry due to metastatic, intraoral squamous cell cancer. Images Courtesy of Charlie Goldberg, M.D., UCSD School of Medicine and VA Medical Center, San Diego, CA.

• 

  Cervical adenopathy: large right anterior cervical lymph node. Images Courtesy of Charlie Goldberg, M.D., UCSD School of Medicine and VA Medical Center, San Diego, CA.

• 

  Cervical lymphadenopathy. Images Courtesy of Charlie Goldberg, M.D., UCSD School of Medicine and VA Medical Center, San Diego, CA.

• 

  Cervical Adenopathy: multiple right sided cervical lymph nodes. Images Courtesy of Charlie Goldberg, M.D., UCSD School of Medicine and VA Medical Center, San Diego, CA.

Laboratory Findings

• Laboratory findings consistent with the diagnosis of lymphadenopathy, may include:

Complete Blood Count

• Elevated lactate dehydrogenase (LDH)
• Mild neutropenia
• Leukocytosis
• Elevated markers of inflammation and acute phase reactants (e.g. ESR, C-reactive protein, ferritin)

Imaging Findings

Ultrasonography

• On ultrasound, characteristic findings of lymphadenopathy, include:

• Increased lymph node size

CT

• On CT, characteristic findings of lymphadenopathy, include:

• Most nodes: 10 mm in short-axis
• Sub-mental and sub-mandibular: 15 mm
• Retropharyngeal: 8 mm
• Loss of fatty hilum
• Focal necrosis
• Cystic necrotic nodes
• Long-to-short axis ratio (>2cm - usually benign)

• The upper limit in size of a normal node varies with location.

PET/CT

• On PET/CT, lymphadenopathy can be further assessed via quantitation of FDG uptake, which is a surrogate of metabolic activity. Infectious, inflammatory, and neoplastic processes will show high FDG avidity on PET/CT. PET/CT is particularly useful for assessing response of lymph nodes to systemic chemotherapy.

MRI

• MRI is the most anatomically precise test for assessing lymphadenopathy. MRI is particularly useful for intraabdominal lymphadenopathy, which cannot be readily palpated via physical examination. MRI is more expensive than CT scan, so CT is preferred in general unless the clinical need for MRI arises.

Treatment

• There is no treatment for lymphadenopathy; the mainstay of therapy is treating the underlying condition.
  • Infectious lymphadenopathy responds well to prompt treatment with antibiotics, and usually leads to a complete recovery. However, it may take months, for swelling to disappear. The amount of time to recovery depends on the cause.
  • Neoplastic (malignant) lymphadenopathy usually responds well to systemic chemotherapy.

References

Template:WikiDoc Sources